SCHEMBL7184772

SCHEMBL7184772

C=C(C)Oc1ccc(C(=O)/C=C/c2ccc(OCC)cc2OCC)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.60
CYP1B1 Q16678 3/20 0.60
TNFRSF1A P19438 1/20 0.52
MAPT P10636 5/20 0.51
LMNA P02545 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ATM Q13315 1/20 0.51
DPP4 P27487 2/20 0.50
PTPN1 P18031 1/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MAOB P27338 5/20 0.49
MAOA P21397 1/20 0.49
HPGD P15428 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184778 1.00 CYP1A1 (0.60) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL7184858 0.91 ABCG2 (0.53) CYP1A1CYP1B1MAPTLMNASMN1; SMN2
SCHEMBL7184857 0.91 ABCG2 (0.53) CYP1A1CYP1B1MAPTLMNASMN1; SMN2
SCHEMBL9115243 0.89 CYP1A1 (0.69) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL9115237 0.89 CYP1A1 (0.69) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL7806482 0.89 CYP1A1 (0.61) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL7185701 0.89 CYP1A1 (0.56) CYP1A1CYP1B1TNFRSF1AMAPTLMNA
SCHEMBL7188820 0.86 DPP4 (0.48) CYP1A1CYP1B1MAPTLMNASMN1; SMN2
SCHEMBL7188822 0.86 DPP4 (0.48) CYP1A1CYP1B1MAPTLMNASMN1; SMN2
SCHEMBL7177114 0.85 MAOB (0.66) CYP1A1CYP1B1TNFRSF1AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed